Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.200
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
2.220
+0.020 (0.91%)
After-hours: Dec 5, 2025, 7:55 PM EST
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 838 employees as of December 31, 2024. The number of employees increased by 281 or 50.45% compared to the previous year.
Employees
838
Change (1Y)
281
Growth (1Y)
50.45%
Revenue / Employee
$298,837
Profits / Employee
-$474,502
Market Cap
873.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IOVA News
- 14 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode - Seeking Alpha
- 25 days ago - Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around? - The Motley Fool
- 4 weeks ago - 2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street - The Motley Fool
- 4 weeks ago - Iovance Biotherapeutics, Inc. (IOVA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders - GlobeNewsWire
- 7 weeks ago - Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health - The Motley Fool
- 7 weeks ago - Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire? - The Motley Fool